Press release
Amebiasis Market Size Projected To Reach 1.13 Billion By 2034 With A Cagr Of 6.6%
Amebiasis Market Size
What Is the Projected Growth of the Amebiasis Market?
The market for amebiasis has been on a strong upward trend of late. The prediction is for it to escalate from $0.82 billion in 2024 to $0.88 billion in 2025, reflecting a 6.9% compound annual growth rate (CAGR). This growth surge in previous years can be linked to escalating rates of amoeba-related infections in warm climate regions, lax sanitation, and inadequate hygiene habits in developing nations, increased overseas travel particularly to areas where the disease is prevalent, heightened disease awareness, and a shortage of uncontaminated drinking water in rural locations.
The amebiasis market is anticipated to witness robust growth over the next few years, expanding to $1.14 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 6.6%. The expected growth within the forecast period can be credited to the rising numbers of immune-compromised individuals, enhanced governmental actions towards bettering sanitation and healare infrastructure, increased funding in researching innovative treatments, an amplified focus on health projects aimed at fighting parasitic illnesses, and a surging requirement for efficient oral drugs. The forecast period is poised to experience major trends such as rising acceptance of combination therapies, vaccine development, advancements in systems for drug delivery, progress in pharmaceutical research, and the creation of novel antiprotozoal pharmaceuticals.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21094
What Are the Different Amebiasis Market Segments?
The amebiasis market covered in this report is segmented -
1) By Type: Metronidazole, Paromomycin, Tinidazole
2) By Route Of Administration: Oral, Intravenous
3) By Application: Hospital, Pharmacy
Subsegments:
1) By Metronidazole: Oral Metronidazole, Intravenous Metronidazole, Combination Therapy with Metronidazole
2) By Paromomycin: Oral Paromomycin, Paromomycin in Combination with Other Drugs
3) By Tinidazole: Oral Tinidazole, Tinidazole for Severe Infections
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21094&type=smp
What Are the Primary Drivers Shaping the Amebiasis Market?
The uptrend in parasitic infections is projected to fuel the expansion of the amebiasis market. The term "parasitic infections" alludes to ailments caused by parasites including protozoa, helminths, and ectoparasites that subsist within or on a host, consuming nutrients to the host's detriment. The rise in parasitic infections can be attributed to factors such as heightened travel, climate change, inadequate sanitation, and increasing drug resistance, all of which collectively facilitate the spread and persistence of these infections. Amebiasis, a disease triggered by the entamoeba histolytica parasite, amplifies parasitic infections by infiltrating the intestines, causing symptoms like diarrhea, abdominal pain and may lead to grave consequences like tissue destruction and liver abscesses. For example, as per the UK-based Animal and Plant Health Agency in January 2024, a total of 1,071 Parasitic Gastroenteritis (PGE) diagnosises were recorded in 2022, inclusive of 190 haemonchosis cases and 95 nematodirosis cases. The caseload of haemonchosis was noticeably elevated compared to the previous year in 2022. Hence, the escalating figures of parasitic infections are enhancing the growth of the amebiasis market. The Impact Of Substandard Sanitation On Market Advancement
Which Companies Are Leading in the Amebiasis Market?
Major companies operating in the amebiasis market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Becton inson and Company, Teva Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Cepheid Inc., Mission Pharmacal Company, Profounda Inc., Zydus Lifesciences Limited
What Trends Are Driving Growth in The Amebiasis Market?
Key players in the amebiasis market are emphasizing the development of enhanced solutions such as ready-to-use oral liquid metronidazole to boost patient adherence and treatment effectiveness. The ready-to-use oral liquid metronidazole is a pre-made liquid antibiotic used for treating infections like amebiasis, providing an easier option for patients who find it hard to swallow tablets. For example, in November 2023, Kesin Pharma Corporation, an American pharmaceutical firm, got the green light from the U.S. Food and Drug Administration for its product, Likmez (metronidazole) oral suspension, in a 500 mg/5 mL dosage - the first ready-to-use oral liquid version of metronidazole. The formulation is child-friendly, making medication intake more manageable and ensuring correct dosing for children, which leads to higher adherence to treatment regimens. The liquid version provides dosage flexibility, permitting healare practitioners to modify treatment according to the specific needs of the patient, especially in cases of varying infection severity.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/amebiasis-global-market-report
What Are the Top Revenue-Generating Geographies in the Amebiasis Market?
North America was the largest region in the amebiasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amebiasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Amebiasis Market?
2. What is the CAGR expected in the Amebiasis Market?
3. What Are the Key Innovations Transforming the Amebiasis Industry?
4. Which Region Is Leading the Amebiasis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Amebiasis Market Size Projected To Reach 1.13 Billion By 2034 With A Cagr Of 6.6% here
News-ID: 4069711 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Amebiasis
Amebiasis Treatment Market Analysis By Application, Type, Technology, and Geogra …
The Amebiasis Treatment Market reached a valuation of 13.54 billion in 2025 and is anticipated to expand at a CAGR of 13.76% during the forecast period from 2026 to 2033, ultimately attaining an estimated value of 37.98 billion by 2033. Market growth is being driven by increasing demand across industrial, commercial, and technology-oriented applications, supported by ongoing innovation, expanding application areas, and rising investments across key end-use industries.
Amebiasis Treatment Market…
Market Trend Analysis: The Impact of Recent Innovations on the Amebiasis Market
The amebiasis market is poised for significant expansion over the coming years, driven by advancements in healthcare and a growing focus on infectious disease management. As awareness and technology improve, this sector is set to witness notable developments that could reshape treatment options and patient outcomes. Let's delve into the market's size projections, key players, prevailing trends, and segment classifications to get a comprehensive understanding of the industry's future.
Projected Expansion…
Amebiasis Market on Track for Strong Growth, Estimated to Grow at 6.5% CAGR Thro …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Amebiasis Market Through 2025?
The market for amebiasis has experienced significant expansion lately, projected to increase its valuation from $0.82 billion in 2024 to $0.88 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.6%; this historical upward trajectory is…
Amebiasis Treatment Market Growth in Future Scope 2025-2032 | Pfizer Inc., Impax …
A new study titled Amebiasis Treatment Market 2024, published by the Coherent Market Insights, offers information on regional and global markets that is expected to increase in value between 2024 and 2031. The extensive research offers important visions into the market's shifting dynamics, value chain analysis, well-known investment hotspots, competitive scenarios, regional landscape, and major segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally,…
Key Trend Reshaping the Amebiasis Market in 2025: Development Of Ready-To-Use Or …
What combination of drivers is leading to accelerated growth in the amebiasis market?
The rising incidence of parasitic infections is expected to propel the amebiasis market. Parasitic infections occur when organisms such as protozoa, helminths, or ectoparasites infect a host and thrive at its expense. The increasing prevalence of these infections is linked to factors such as international travel, climate change, poor sanitation, and the development of drug-resistant parasites, all of…
Comprehensive Growth Forecast for Amebiasis Treatment Market: Segmentation Analy …
Amebiasis Treatment Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Amebiasis Treatment Market Scope: Unveiling Today's Trends
Amebiasis Treatment refers to the medical interventions aimed at controlling amebiasis, an intestinal infection caused by the parasite Entamoeba histolytica. The market for these treatments is currently experiencing notable trends, including a rise in the prevalence of gastrointestinal infections and increased awareness about amebiasis, leading to higher demand for effective therapies. The market size…
